FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder

Links shared publicly online about this topic.

  • 1,564
    total visits

FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder

drugs.com

Cymbalta (duloxetine) is used for the maintenance treatment of generalized anxiety disorder. Includes Cymbalta side effects, interactions and indications.

View full resource at drugs.com

Tags: Anxiety Medication, Generalized Anxiety Disorder, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, Disease and Condition, FDA, Cymbalta

  • Share

Most Recently Shared on November 30, 2009 at 11:46 pm By:

drugscom Drugs.com

FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder - http://bit.ly/8jffpy

2 years ago...

FDA approves Cymbalta as maintenance drug for anxiety disorder - Related Stories - AANP SmartBrief

smartbrief.com — “The FDA cleared Eli Lilly and Co. to market Cymbalta as a maintenance therapy for generalized anxiety disorder. Cymbalta, which was first approved in 2004 as an antidepressant, already has FDA approval to treat acute attacks of generalized anxiety disorder. View full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on December 1, 2009 at 4:25 pm By:

forgrace Women In Pain Health Organization

FDA approves Cymbalta as maintenance drug for anxiety disorder http://sbne.ws/r/3mH8

2 years ago...

Cymbalta approved for maintenance treatment of generalized anxiety disorder (GAD) - MPR

empr.com — “The FDA has approved Cymbalta (duloxetine HCl, from Lilly) for the maintenance treatment of generalized anxiety disorder (GAD) in adults.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on November 30, 2009 at 4:52 pm By:

eMPR MPR Medical Publisher

MPR News: Cymbalta approved for maintenance treatment of generalized anxiety disorder (GAD): The FDA has approved C... http://bit.ly/5AU8sB

2 years ago...

Eli Lilly and Company - FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

newsroom.lilly.com — “Eli Lilly and Company - FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety DisorderView full resource at newsroom.lilly.com

  • View Related
  • Share

Most Recently Shared on November 30, 2009 at 2:41 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder - http://ow.ly/H9vE

2 years ago...

Advertisement